MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 100 filers reported holding MYOVANT SCIENCES LTD in Q3 2022. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,309,394 | +23.3% | 122,752 | -17.9% | 0.00% | +50.0% |
| Q3 2022 | $2,685,000 | +99.8% | 149,519 | +38.3% | 0.00% | +100.0% |
| Q2 2022 | $1,344,000 | +118.2% | 108,131 | +133.8% | 0.00% | – |
| Q1 2022 | $616,000 | -79.1% | 46,247 | -75.6% | 0.00% | -100.0% |
| Q4 2021 | $2,947,000 | +29.4% | 189,269 | +86.6% | 0.00% | +100.0% |
| Q3 2021 | $2,277,000 | -43.3% | 101,457 | -42.5% | 0.00% | -50.0% |
| Q2 2021 | $4,019,000 | +12078.8% | 176,491 | +10794.5% | 0.00% | – |
| Q1 2021 | $33,000 | +13.8% | 1,620 | +56.8% | 0.00% | – |
| Q4 2020 | $29,000 | +93.3% | 1,033 | -0.2% | 0.00% | – |
| Q3 2020 | $15,000 | -89.5% | 1,035 | -85.1% | 0.00% | – |
| Q2 2020 | $143,000 | +14200.0% | 6,944 | +5367.7% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 127 | -5.9% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 135 | +104.5% | 0.00% | – |
| Q4 2018 | $1,000 | – | 66 | +340.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 15 | -63.4% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 41 | -12.8% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 47 | -57.7% | 0.00% | – |
| Q1 2017 | $1,000 | -99.2% | 111 | -99.0% | 0.00% | – |
| Q4 2016 | $133,000 | – | 10,701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VitalStone Financial, LLC | 15 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |